000144612 001__ 144612
000144612 005__ 20230425171544.0
000144612 0247_ $$2doi$$a10.1016/B978-0-444-63486-3.00011-6
000144612 0247_ $$2ISSN$$a0079-6123
000144612 0247_ $$2ISSN$$a1875-7855
000144612 0247_ $$2altmetric$$aaltmetric:2930740
000144612 0247_ $$2pmid$$apmid:25410361
000144612 037__ $$aDZNE-2020-00124
000144612 082__ $$a610
000144612 1001_ $$0P:(DE-HGF)0$$aPitkänen, Asla$$b0$$eCorresponding author
000144612 245__ $$aNeural ECM and epilepsy
000144612 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2014
000144612 29510 $$aBrain Extracellular Matrix in Health and Disease / Pitkänen, Asla  ;  : Elsevier, 2014,  ; ISSN: 00796123 ; ISBN: 9780444634863 ; doi:10.1016/B978-0-444-63486-3.00011-6
000144612 300__ $$a229 - 262
000144612 3367_ $$2ORCID$$aBOOK_CHAPTER
000144612 3367_ $$07$$2EndNote$$aBook Section
000144612 3367_ $$2DRIVER$$abookPart
000144612 3367_ $$2BibTeX$$aINBOOK
000144612 3367_ $$2DataCite$$aOutput Types/Book chapter
000144612 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book$$bcontb$$mcontb$$s1591362006_14122
000144612 4900_ $$aProgress in Brain Research$$v214
000144612 536__ $$0G:(DE-HGF)POF3-342$$a342 - Disease Mechanisms and Model Systems (POF3-342)$$cPOF3-342$$fPOF III$$x0
000144612 588__ $$aDataset connected to CrossRef Book Series
000144612 650_2 $$2MeSH$$aAnimals
000144612 650_2 $$2MeSH$$aAnticonvulsants: therapeutic use
000144612 650_2 $$2MeSH$$aEpilepsy: drug therapy
000144612 650_2 $$2MeSH$$aEpilepsy: metabolism
000144612 650_2 $$2MeSH$$aEpilepsy: pathology
000144612 650_2 $$2MeSH$$aExtracellular Matrix: drug effects
000144612 650_2 $$2MeSH$$aExtracellular Matrix: physiology
000144612 650_2 $$2MeSH$$aHumans
000144612 650_2 $$2MeSH$$aReceptors, Urokinase Plasminogen Activator: drug effects
000144612 650_2 $$2MeSH$$aReceptors, Urokinase Plasminogen Activator: metabolism
000144612 7001_ $$aNdode-Ekane, Xavier E.$$b1
000144612 7001_ $$aŁukasiuk, Katarzyna$$b2
000144612 7001_ $$aWilczynski, Grzegorz M.$$b3
000144612 7001_ $$0P:(DE-2719)2810577$$aDityatev, Alexander$$b4$$udzne
000144612 7001_ $$aWalker, Matthew C.$$b5
000144612 7001_ $$aChabrol, Elodie$$b6
000144612 7001_ $$aDedeurwaerdere, Stefanie$$b7
000144612 7001_ $$aVazquez, Naiara$$b8
000144612 7001_ $$aPowell, Elizabeth M.$$b9
000144612 773__ $$a10.1016/B978-0-444-63486-3.00011-6
000144612 909CO $$ooai:pub.dzne.de:144612$$pVDB
000144612 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810577$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000144612 9131_ $$0G:(DE-HGF)POF3-342$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$aDE-HGF$$bForschungsbereich Gesundheit$$lErkrankungen des Nervensystems$$vDisease Mechanisms and Model Systems$$x0
000144612 9141_ $$y2014
000144612 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPROG BRAIN RES : 2018$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-01-15
000144612 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-15
000144612 9201_ $$0I:(DE-2719)1310007$$kAG Dityatev$$lMolecular Neuroplasticity$$x0
000144612 980__ $$acontb
000144612 980__ $$aVDB
000144612 980__ $$aI:(DE-2719)1310007
000144612 980__ $$aUNRESTRICTED